Alexander, a partner in McKinsey’s Zurich office since 2014, is deeply passionate about the life sciences industry. Demonstrating a commitment to client success, he specializes in stabilizing and optimizing operations, fostering ambitious growth, delivering substantial bottom-line impact, and enhancing resilience to navigate current and future challenges.
With a track record of leadership and successful collaborations in full-scale operations transformations, Alexander’s expertise extends to diverse sectors, including pharma, biotech, med-tech, and consumer health. Key focus areas include procurement, supply chain management, and external manufacturing.
Examples of Alexander’s recent work include:
- ramping up internal and external manufacturing capacities for the first commercial product supply with a global mRNA vaccine manufacturer, including identifying throughput increase potential by 1.5-3X
- helping conduct a holistic operations transformation for an Eastern European pharma company, achieving a significant reduction in lost sales through improvements in supply chain planning and manufacturing throughput
- guiding a multiyear operations transformation with a global generics company headquartered in Africa, involving the optimization of four manufacturing sites in Europe and Africa, procurement value capture, and organizational redesign
- collaborating on a supply chain transformation as part of a major TechOps transformation for a leading Swiss pharma player, including strategy definition, target state process, and organizational design covering all supply chain processes
- redesigning the global supply chain in collaboration with a leading generic drugs company, including holistic supply chain performance assessment, benchmarking, and design of the future supply chain setup
- assisting with the execution of an 18-month procurement transformation with a leading global biotech player in the Nordics, focusing on global indirect spend categories and achieving savings of 10-14% per category
- preparing negotiations for a diverse portfolio of externally sourced products with a top generics company, based on cleansheet cost modeling
- defining external supply and CMO footprint strategy with a leading pharma business, including a comprehensive supply market analysis for specific geographies and technologies, and assessment of transfer economics
- collaborating on the development of the strategy, operating model, and organizational structure for the external supply operations of a leading pharma business, including supplier footprint assessment, target state design, operating model, and organizational design